Pages that link to "Q57602286"
Jump to navigation
Jump to search
The following pages link to Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor (Q57602286):
Displaying 50 items.
- Circulating tumors cells as biomarkers: progress toward biomarker qualification (Q26852579) (← links)
- Detection of circulating tumor cells (Q26859334) (← links)
- Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back (Q28070333) (← links)
- Molecular biomarker analyses using circulating tumor cells (Q28749394) (← links)
- Insulin and insulin-like growth factor signalling in neoplasia (Q29619495) (← links)
- Circulating tumor cell analysis: technical and statistical considerations for application to the clinic (Q33559406) (← links)
- Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse (Q33979359) (← links)
- The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study (Q34059707) (← links)
- Circulating tumor cells in colorectal cancer: past, present, and future challenges (Q34097734) (← links)
- All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer. (Q34098110) (← links)
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study (Q34139534) (← links)
- Flat-top illumination profile in an epifluorescence microscope by dual microlens arrays (Q34185423) (← links)
- Circulating Tumor Cells as Biomarkers in Prostate Cancer (Q34193303) (← links)
- Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular-signal-regulated kinase and DNA in circulating tumor cells (Q34231456) (← links)
- Regulation of insulin-like growth factor signaling by metformin in endometrial cancer cells (Q34293099) (← links)
- Can we unlock the potential of IGF-1R inhibition in cancer therapy? (Q34336988) (← links)
- Lycopene Enhances Docetaxel's Effect in Castration-Resistant Prostate Cancer Associated with Insulin-like Growth Factor I Receptor Levels (Q34551541) (← links)
- Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients (Q34590296) (← links)
- Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer. (Q34796583) (← links)
- Pathology: are circulating tumor cells predictive of overall survival? (Q34971716) (← links)
- Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials (Q35006620) (← links)
- Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer (Q35006907) (← links)
- Circulating tumour cells: their utility in cancer management and predicting outcomes (Q35076325) (← links)
- Visceral adiposity, insulin resistance and cancer risk (Q35133640) (← links)
- The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. (Q35190869) (← links)
- Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy (Q35204595) (← links)
- Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia (Q35577352) (← links)
- Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha (Q35915267) (← links)
- The insulin receptor: a new target for cancer therapy (Q35972002) (← links)
- Rare cell isolation and recovery on open-channel microfluidic chip (Q36352034) (← links)
- Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients (Q36642164) (← links)
- pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma (Q36771900) (← links)
- Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer (Q36935959) (← links)
- Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients (Q37038658) (← links)
- Detection, clinical relevance and specific biological properties of disseminating tumour cells (Q37135356) (← links)
- Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity (Q37180380) (← links)
- The insulin-like growth factor system and its receptors: A potential novel anticancer target (Q37307864) (← links)
- Regulation of breast cancer metastasis by IGF signaling (Q37334032) (← links)
- IGF-1R as an anti-cancer target--trials and tribulations (Q37353958) (← links)
- Implications of insulin-like growth factor-I for prostate cancer therapies (Q37381766) (← links)
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions (Q37542952) (← links)
- Figitumumab (CP-751,871) for cancer therapy (Q37696484) (← links)
- Insulin-like growth factor receptor type I as a target for cancer therapy (Q37773265) (← links)
- Early Oncology Clinical Trial Design in the Era of Molecular-Targeted Agents (Q37783623) (← links)
- RETRACTED: Horizon scanning for novel therapeutics for the treatment of prostate cancer (Q37792060) (← links)
- Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials (Q37877010) (← links)
- Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy. (Q37898107) (← links)
- Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies (Q37903335) (← links)
- Targeting IGF-1 signaling pathways in gynecologic malignancies (Q38072115) (← links)
- Translating metastasis-related biomarkers to the clinic--progress and pitfalls (Q38079125) (← links)